Further, both eEF2K and JNK inhibitors suppressed tumor growth of cell line xenografts, reflecting a relationship between p53, PTEN and eEF2K that can be therapeutically targeted (a simplified pathway overview is given in Fig 1). Here, TP53 is linked to neoplasm.